Xofluza

Chemical Namebaloxavir marboxil
Dosage FormTablet (oral; 20 mg, 40 mg)
Drug ClassAntivirals
SystemRespiratory
CompanyGenentech Inc.
Approval Year2018

Indication

  • To treat acute uncomplicated influenza in healthy patients or patients who are at risk for influenza-related complications ≥ 12 years of age who have been presenting symptoms for ≤ 48 hours.
Last updated on 11/11/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xofluza (Baloxavir Marboxil) Prescribing Information2018Genentech USA, Inc., South San Francisco, CA